FIELD: pharmacy.
SUBSTANCE: pharmaceutical composition exhibiting specific anti-inflammatory activity on experimental dysbiosis model consisting of strains of Bifidobacterium longum GT15, Lactobacillus rhamnosus K32, Enterococcus faecium L-3.
EFFECT: increasing the effectiveness of the composition in the treatment of inflammatory bowel disease.
18 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNBIOTIC COMPOSITION FOR CORRECTION OF DYSBIOTIC GASTROINTESTINAL TRACT MICROBIOCENOSIS DISTURBANCES | 2015 |
|
RU2592988C1 |
| METABIOTIC COMPOSITION TO ENSURE COLONISATION RESISTANCE OF HUMAN INTESTINAL MICROBIOCENOSIS | 2015 |
|
RU2589818C1 |
| APPLICATION OF PROBIOTIC STRAIN OF ENTEROCOCCUS FAECIUM L-3 MICROORGANISM FOR NEURODEGENERATIVE DISEASES TREATMENT | 2014 |
|
RU2642246C2 |
| STRAIN OF Lactobacillus fermentum Z, USED FOR PRODUCTION OF PROBIOTIC CULTURED MILK FOODS | 2008 |
|
RU2412239C2 |
| METHOD FOR PREPARING AN AUTOPROBIOTIC BASED ON AN ANAEROBIC CONSORTIUM OF BACTERIA | 2018 |
|
RU2734896C2 |
| PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
| METHOD OF OBTAINING PERSONIFIED AUTOPROBIOTIC PRODUCT AND METHOD OF TREATING SYNDROME OF IRRITABLE BOWL WITH THEREOF APPLICATION | 2013 |
|
RU2546253C2 |
| METHOD FOR PRODUCING AUTOPROBIOTIC OF ENTEROCUCCUS FAECIUM BEING REPRESENTATIVE OF INDIGENIC HOST INTESTINAL MICROFLORA | 2010 |
|
RU2460778C1 |
| RECOVERING, IDENTIFYING AND DESCRIBING STRAINS WITH PROBIOTIC ACTIVITY RECOVERED FROM FAECES OF EXCLUSIVELY BREAST-FED CHILDREN | 2010 |
|
RU2551315C2 |
| METHOD FOR MONOTHERAPY OF GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 2020 |
|
RU2758246C1 |
